Proteome Sciences (CHIX:PRML) Ending Cash Position: £0.78 Mil (As of Dec. 2025)


What is Proteome Sciences Ending Cash Position?

Proteome Sciences CHIX:PRML +7.63% Ending Cash Position is £0.78 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Proteome Sciences's Ending Cash Position for the quarter that ended in Dec. 2025 was £0.78 Mil.

Proteome Sciences's quarterly Ending Cash Position declined from Dec. 2024 (£1.13 Mil) to Jun. 2025 (£0.26 Mil) but then increased from Jun. 2025 (£0.26 Mil) to Dec. 2025 (£0.78 Mil).

Proteome Sciences's annual Ending Cash Position declined from Dec. 2023 (£2.03 Mil) to Dec. 2024 (£1.13 Mil) and declined from Dec. 2024 (£1.13 Mil) to Dec. 2025 (£0.78 Mil).

Proteome Sciences Ending Cash Position Related Terms

Proteome Sciences Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Proteome Sciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences Ending Cash Position Chart

Proteome Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 3.99 2.03 1.13 0.78

Proteome Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.03 1.21 1.13 0.26 0.78

Proteome Sciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Proteome Sciences's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.128+-0.347
=0.78

Proteome Sciences's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.093+0.688
=0.78

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of £0.78 Mil mean?
Proteome Sciences (CHIX:PRML) has a Ending Cash Position of £0.78 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Proteome Sciences and its competitors.
Is Proteome Sciences' Ending Cash Position too high?
Proteome Sciences' current Ending Cash Position is £0.78 Mil.
How does Proteome Sciences' Ending Cash Position compare to TMO and DHR?
Proteome Sciences' Ending Cash Position of £0.78 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Diagnostics & Research company?
A good Ending Cash Position depends on the Medical Diagnostics & Research industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Proteome Sciences and its competitors. Proteome Sciences's current Ending Cash Position is £0.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Based on GuruFocus' analysis, Proteome Sciences (CHIX:PRML) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 29.5% below its estimated fair value. The current Ending Cash Position is £0.78 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Proteome Sciences (CHIX:PRML), the current Ending Cash Position is £0.78 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proteome Sciences Business Description

Other Exchanges PRM:UKPI2:Germany
Address Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.